SCHEMBL15701034

SCHEMBL15701034

O=C(Nc1ccc2nc(NC(=O)C3(c4cccc(C(F)(F)F)c4)CCC3)sc2c1)c1cscn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 10/20 0.44
DYRK1A Q13627 1/20 0.41
CYP2C9 P11712 5/20 0.40
ACP1 P24666 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP2C8 P10632 3/20 0.40
CYP2D6 P10635 1/20 0.40
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
AGTR1 P30556 1/20 0.39
OPRK1 P41145 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17148310 0.98 CSNK1D (0.44) CSNK1DDYRK1ACYP2C9ACP1CYP3A4
SCHEMBL15701267 0.97 CSNK1D (0.45) CSNK1DDYRK1ACYP2C9ACP1CYP3A4
SCHEMBL15701140 0.89 RAB9A (0.44) CSNK1DMAPTKDM4EMEN1ALDH1A1
SCHEMBL15701098 0.85 RAB9A (0.45) CSNK1DDYRK1AMAPTKDM4EMEN1
SCHEMBL15701258 0.84 CYP2C9 (0.38) CYP2C9CYP3A4MAPTKDM4EMEN1
SCHEMBL15701257 0.83 DHODH (0.52) CSNK1DDYRK1AMAPTKDM4EMEN1
SCHEMBL15701137 0.83 DHODH (0.52) CSNK1DDYRK1AMAPTKDM4EMEN1
SCHEMBL17148441 0.82 CYP2C9 (0.44) CSNK1DCYP2C9CYP3A4CYP2C8CYP2D6
SCHEMBL15701111 0.81 CSNK1D (0.69) CSNK1DCYP2C9CYP3A4
SCHEMBL15701141 0.81 RAF1 (0.44) CSNK1DMAPTKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2914592-B1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INT (DE) 2017-10-11 EP disclosed
US-9334249-B2 Inhibitors of cytomegalovirus BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-05-10 US disclosed
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-08 US disclosed
WO-2014070979-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS CDKN1A, CCNA1, IFNAR1 CSNK1D 247/4885DYRK1A 3952/4885CYP2C9 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.